A new model of care for familial hypercholesterolaemia from Western Australia: closing a major gap in preventive cardiology

Gerald F Watts; Frank M van Bockxmeer; Timothy Bates; John R Burnett; Amanda Juniper; Peter O'Leary

doi:10.1016/j.hlc.2010.02.002

A new model of care for familial hypercholesterolaemia from Western Australia: closing a major gap in preventive cardiology

Heart Lung Circ. 2010 Jul;19(7):419-22. doi: 10.1016/j.hlc.2010.02.002. Epub 2010 Apr 3.

Authors

Gerald F Watts¹, Frank M van Bockxmeer, Timothy Bates, John R Burnett, Amanda Juniper, Peter O'Leary

Affiliation

¹ Lipid Disorders Clinic, Department of Internal Medicine, Royal Perth Hospital, WA 6847, Australia. gerald.watts@uwa.edu.au

PMID: 20363671
DOI: 10.1016/j.hlc.2010.02.002

Abstract

Familial hypercholesterolaemia (FH) is the most common monogenic cause of premature coronary artery disease. FH remains underdiagnosed and inadequately treated, with no national strategies for dealing with the problem. We report an executive summary of a comprehensive model of care for FH developed in Western Australia.

MeSH terms

Adolescent
Adult
Algorithms*
Cardiovascular Diseases / prevention & control*
Child
Critical Pathways
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hyperlipoproteinemia Type II / diagnosis*
Hyperlipoproteinemia Type II / drug therapy*
Male
Middle Aged
Patient Care Team
Patient Selection*
Preventive Health Services
Risk Reduction Behavior
Western Australia
Young Adult

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors